Sofia Cabral

Sofia Cabral

Auto-generated profile, based on publicly available information

Sofia Cabral

Centro Hospitalar Universitário do Porto, Portugal; Universidade do Porto, Portugal

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2015 in Journal of Cardiovascular Pharmacology and Therapeutics
Verified
Journal Article
Open access
ALAndré Luz
André Luz
MSMário Santos
Mário Santos
RMRui Magalhães
Rui Magalhães
JSJoão Silveira
João Silveira
SCSofia Cabral
Sofia Cabral
STSevero Torres
Severo Torres
The underutilization of manual thrombus aspiration (MTA) may have reduced the benefits of ischemic postconditioning (PostCon), as it reduces thrombus embolization. We aimed to assess the benefits of PostCon in patients with ST-segment elevation myocardial infarction (STEMI) after the systematic utilization of MTA. A total of 87 patients were enrolled in a prospective, randomized trial (43 PostCon and 44 controls). After MTA, PostCon was performed on the treatment group by applying 4 cycles of alternate reperfusion and reocclusion (60 seconds each) using the angioplasty balloon. The primary end point was infarct size assessed by the area under the curve (AUC) of troponin T (TnT) activity. The secondary end points were left ventricle ejection fraction (LVEF) and major cardiac events (new myocardial infarction or cardiac death) both at discharge and at follow-up. The AUC for TnT was no different with respect to study arms (median [interquartile range]): PostCon = 8.9 (10.6) versus control = 8.2 (10.6), P = .68. Left ventricle ejection fraction improved from in-hospital to follow-up (9 ± 3 months) for the entire cohort (46.3% ± 7.3% vs 52.2% ± 10.7%, P < .001), with no differences between PostCon and controls (51.6% ± 9.5% vs 52.7% ± 11.9%, P = .89); major cardiac events at 14 ± 4 months of follow-up were also no different (PostCon = 1.0 (2.3%) vs control = 0, P = .49). In patients with STEMI treated with MTA, PostCon offered no benefits to infarct size, LVEF, or major cardiac events.

30 November 2024 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
SCSofia Cabral
Sofia Cabral
CGCristina Gavina
Cristina Gavina
MAManuel Almeida
Manuel Almeida
ASAlexandra Sousa
Alexandra Sousa
AFAna Rita Francisco
Ana Rita Francisco
HPHélder Pereira
Hélder Pereira
The Strategic Plan for Cardiovascular Health in Portugal is an initiative of the Portuguese Society of Cardiology, aligned with efforts by the European Society of Cardiology and the World Heart Federation to develop national plans, at a local level within the cultural and socio-economic contexts, focused on cardiovascular health. The overarching goal is to promote and ensure the continuous and sustained improvement of cardiovascular health in the Portuguese population.The methodology identified key challenges and opportunities for the medium term, highlighted priority areas for intervention, and proposed strategic lines of action. This article outlines the project's design and establishes a guiding framework for the proposed actions, which will be drawn up by designated expert groups and communicated subsequently.

1 January 2018 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
ISInês Silveira
Inês Silveira
MOMarta Oliveira
Marta Oliveira
CGCatarina Gomes
Catarina Gomes
SCSofia Cabral
Sofia Cabral
ALAndré Luz
André Luz
STSevero Torres
Severo Torres

29 July 2022 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
SCSofia Cabral
Sofia Cabral
No início de 2020, o mundo enfrentou o aparecimento de uma nova pandemia, a Doença do Coronavírus 2019 (COVID-19), causada por um novo coronavírus (vírus SARS-CoV-2). Rapidamente descobrimos que, embora o trato respiratório fosse o principal alvo, muitos outros sistemas de orgãos também podiam ser afetados. As manifestações cardiovasculares (CV) da COVID-19 estão entre as mais comuns e temidas e podem se apresentar como lesão miocárdica, arritmias, síndromes coronarianas agudas, insuficiência cardíaca, disfunção vascular e doença tromboembólica. Tanto a doença

19 March 2025 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
SCSofia Cabral
Sofia Cabral
CGCristina Gavina
Cristina Gavina
MAManuel Almeida
Manuel Almeida
ASAlexandra Sousa
Alexandra Sousa
AFAna Rita Francisco
Ana Rita Francisco
HPHélder Pereira
Hélder Pereira
The Strategic Plan for Cardiovascular Health in Portugal is an initiative of the Portuguese Society of Cardiology, developed together with the European Society of Cardiology to create a European Cardiovascular Health Plan, an initiative which has now been endorsed by the Council of the European Union. Building upon its conceptual framework, the Portuguese Society of Cardiology moved to the implementation phase by establishing Working Groups composed of experts in priority areas. Guided by strategic pillars, these groups formulated proposals for action encompassing health promotion, primary prevention and health determinants, screening and early diagnosis, secondary prevention, as well as rehabilitation and quality of life promotion. This document outlines the results and messages from this project.

1 May 2021 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
SCSofia Cabral
Sofia Cabral